Methods of treating neuroinflammation and inhibiting monoamine oxidase-a and restoring/upregulating/increasing il-13 and and pgc-1 by administering oral dosage form containing micronized and nonmicronized particulate metaxalone, alginic acid and propylene glycol alginate
AssigneePrimus Pharmaceuticals, Inc.
InventorsFrancesco Squadrito, James C. Lukban, Ryan E. Hartung, Garrett A. Campbell
Life of this patent
Estimating the term…